Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial

Gerald W. Prager; J Taïeb; Marwan Fakih; Fortunato Ciardiello; E Van Cutsem; Elena Elez; F. Cruz; Lucjan Wyrwicz; D. Stroyakovskiy; Zsuzsanna Papai; Pierre-guillaume Poureau; Gabor Liposits; Chiara Cremolini; I. Bondarenko; D Modest; N Amellal; H. Hassan; Donia Skanji; Josep Tabernero

doi:10.1016/j.annonc.2023.04.024

Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial

Gerald W. Prager, J Taïeb, Marwan Fakih, Fortunato Ciardiello, E Van Cutsem, Elena Elez, F. Cruz, Lucjan Wyrwicz, D. Stroyakovskiy, Zsuzsanna Papai, Pierre-guillaume Poureau, Gabor Liposits, Chiara Cremolini, I. Bondarenko, D Modest, N Amellal, H. Hassan, Donia Skanji, Josep Tabernero

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	1
Tidsskrift	Annals of Oncology
Vol/bind	34
Udgave nummer	Suppl. 1
Sider (fra-til)	184
ISSN	0923-7534
DOI	https://doi.org/10.1016/j.annonc.2023.04.024
Status	Udgivet - 27. jun. 2023
Begivenhed	World Congress on Gastrointestinal Cancer 2023: ESMO GI - Barcelona Varighed: 28. jun. 2023 → 1. jul. 2023

Konference

Konference	World Congress on Gastrointestinal Cancer 2023
By	Barcelona
Periode	28/06/2023 → 01/07/2023

Dokumenter og links

10.1016/j.annonc.2023.04.024

Citationsformater

Prager, G. W., Taïeb, J., Fakih, M., Ciardiello, F., Van Cutsem, E., Elez, E., Cruz, F., Wyrwicz, L., Stroyakovskiy, D., Papai, Z., Poureau, P., Liposits, G., Cremolini, C., Bondarenko, I., Modest, D., Amellal, N., Hassan, H., Skanji, D., & Tabernero, J. (2023). Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial. Annals of Oncology, 34(Suppl. 1), 184. Artikel 1. https://doi.org/10.1016/j.annonc.2023.04.024

@article{5ecff87226544d1584a1071c4bbabe05,

title = "Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial",

author = "Prager, {Gerald W.} and J Ta{\"i}eb and Marwan Fakih and Fortunato Ciardiello and {Van Cutsem}, E and Elena Elez and F. Cruz and Lucjan Wyrwicz and D. Stroyakovskiy and Zsuzsanna Papai and Pierre-guillaume Poureau and Gabor Liposits and Chiara Cremolini and I. Bondarenko and D Modest and N Amellal and H. Hassan and Donia Skanji and Josep Tabernero",

year = "2023",

month = jun,

day = "27",

doi = "10.1016/j.annonc.2023.04.024",

language = "English",

volume = "34",

pages = "184",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier",

number = "Suppl. 1",

note = "World Congress on Gastrointestinal Cancer 2023 : ESMO GI, WCGIC 2023 ; Conference date: 28-06-2023 Through 01-07-2023",

}

Prager, GW, Taïeb, J, Fakih, M, Ciardiello, F, Van Cutsem, E, Elez, E, Cruz, F, Wyrwicz, L, Stroyakovskiy, D, Papai, Z, Poureau, P, Liposits, G, Cremolini, C, Bondarenko, I, Modest, D, Amellal, N, Hassan, H, Skanji, D & Tabernero, J 2023, 'Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial', Annals of Oncology, bind 34, nr. Suppl. 1, 1, s. 184. https://doi.org/10.1016/j.annonc.2023.04.024

Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial. / Prager, Gerald W.; Taïeb, J; Fakih, Marwan et al.
I: Annals of Oncology, Bind 34, Nr. Suppl. 1, 1, 27.06.2023, s. 184.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Health-related quality of life associated with trifluridine/ tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial

AU - Prager, Gerald W.

AU - Taïeb, J

AU - Fakih, Marwan

AU - Ciardiello, Fortunato

AU - Van Cutsem, E

AU - Elez, Elena

AU - Cruz, F.

AU - Wyrwicz, Lucjan

AU - Stroyakovskiy, D.

AU - Papai, Zsuzsanna

AU - Poureau, Pierre-guillaume

AU - Liposits, Gabor

AU - Cremolini, Chiara

AU - Bondarenko, I.

AU - Modest, D

AU - Amellal, N

AU - Hassan, H.

AU - Skanji, Donia

AU - Tabernero, Josep

PY - 2023/6/27

Y1 - 2023/6/27

U2 - 10.1016/j.annonc.2023.04.024

DO - 10.1016/j.annonc.2023.04.024

M3 - Conference abstract in journal

SN - 0923-7534

VL - 34

SP - 184

JO - Annals of Oncology

JF - Annals of Oncology

IS - Suppl. 1

M1 - 1

T2 - World Congress on Gastrointestinal Cancer 2023

Y2 - 28 June 2023 through 1 July 2023

ER -